B6;129P2-Rhdtm1Goo Rhagtm1Goo/Orl

Status

Available to order

EMMA IDEM:11708
International strain nameB6;129P2-Rhdtm1Goo Rhagtm1Goo/Orl
Alternative nameGOO1 x GOO2 also Rhdtm1GOOxRhagtm1GOO (MGI:5318588x5318589)
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolRhdtm1Goo, Rhagtm1Goo
Gene/Transgene symbolRhd, Rhag

Information from provider

ProviderDominique GOOSSENS
Provider affiliationUMRS_1134-Inserm-Dept de recherches biologiques sur le globule rouge, Institut National de la Transfusion Sanguine- Inserm
Genetic informationRhd and Rhag (erythrocyte membrane proteins) gene knockout cross (double knockout).
Phenotypic informationHomozygous:
No clinical abnormalities, complete loss of Rhd and Rhag and mouse RH erythrocyte complex proteins, disruption of erythrocyte ammonium transport.

Heterozygous:
normal
References
  • Generation and characterisation of Rhd and Rhag null mice.;Goossens Dominique, Trinh-Trang-Tan Marie-Marcelle, Debbia Martine, Ripoche Pierre, Vilela-Lamego Camilo, Louache Fawzia, Vainchenker William, Colin Yves, Cartron Jean-Pierre, ;2010;British journal of haematology;148;161-72; 19807729
  • Generation of mice with inactivated Rh or Rhag genes.;Goossens D, Bony V, Gane P, Colin Y, Cartron J-P, ;2006;Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine;13;164-6; 16581281
  • Role of RhAG and AQP1 in NH3 and CO2 gas transport in red cell ghosts: a stopped-flow analysis.;Ripoche P, Goossens D, Devuyst O, Gane P, Colin Y, Verkman A S, Cartron J-P, ;2006;Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine;13;117-22; 16574458
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredyes
Immunocompromisedno

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivinghomozygous 129 x C57BL/6, homozygous 129 x C57BL/6
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • abnormal thymus morphology / IMPC
  • increased circulating cholesterol level / IMPC
  • increased exploration in new environment / IMPC
  • decreased mean corpuscular hemoglobin / IMPC
  • decreased hemoglobin content / IMPC
  • enlarged lymph nodes / IMPC
  • decreased mean corpuscular hemoglobin concentration / IMPC
  • decreased mean corpuscular hemoglobin / IMPC
  • abnormal lymph node morphology / IMPC
  • decreased mean corpuscular volume / IMPC
  • decreased circulating cholesterol level / IMPC
  • abnormal skin condition / IMPC
  • small testis / IMPC
  • abnormal testis morphology / IMPC
  • increased circulating total protein level / IMPC
  • increased circulating HDL cholesterol level / IMPC
  • decreased circulating free fatty acids level / IMPC
  • enlarged heart / IMPC
  • decreased circulating alkaline phosphatase level / IMPC
  • decreased circulating HDL cholesterol level / IMPC
  • abnormal heart morphology / IMPC
  • enlarged thymus / IMPC
MGI phenotypes (gene matching)
  • abnormal erythrocyte physiology / MGI
  • increased circulating iron level / MGI
  • abnormal blood homeostasis / MGI
  • decreased mean corpuscular volume / MGI
  • decreased hemoglobin content / MGI
  • abnormal erythrocyte physiology / MGI
  • decreased mean corpuscular hemoglobin concentration / MGI
  • increased circulating iron level / MGI

Literature references

  • Generation and characterisation of Rhd and Rhag null mice.;Goossens Dominique, Trinh-Trang-Tan Marie-Marcelle, Debbia Martine, Ripoche Pierre, Vilela-Lamego Camilo, Louache Fawzia, Vainchenker William, Colin Yves, Cartron Jean-Pierre, ;2010;British journal of haematology;148;161-72; 19807729
  • Generation of mice with inactivated Rh or Rhag genes.;Goossens D, Bony V, Gane P, Colin Y, Cartron J-P, ;2006;Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine;13;164-6; 16581281
  • Role of RhAG and AQP1 in NH3 and CO2 gas transport in red cell ghosts: a stopped-flow analysis.;Ripoche P, Goossens D, Devuyst O, Gane P, Colin Y, Verkman A S, Cartron J-P, ;2006;Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine;13;117-22; 16574458

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).